The "Man Van" reached almost 3,500 men, 85% of whom showed up for scheduled screening exams. Almost 100 prostate cancers were ...

A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a sign ...

There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic ...